Topical compositions to treat circulatory disorders
AssigneeJcds Holdings, LLC
InventorJay Richard Ray, II
Life of this patent
Estimating the term…
Abstract
The invention relates to transdermal compositions including nifedipine, pentoxifylline, ketamine hydrochloride, gabapentin, lidocaine, and prilocaine that may be used to treat conditions such as circulatory disorders and peripheral neuropathy. Additionally, methods of the invention are directed to treating conditions such as circulatory disorders, peripheral neuropathy, wound healing, blood flow issues, or the like, comprising the steps of transdermal or topical administration of the compositions.
Claims24
A pharmaceutical composition consisting of nifedipine, pentoxifylline, ketamine hydrochloride, gabapentin, lidocaine or a pharmaceutically acceptable salt thereof, prilocaine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
A pharmaceutical composition consisting of:
- a) nifedipine in an amount of about 10%;
- b) pentoxifylline in an amount of about 5%;
- c) ketamine hydrochloride in an amount of about 10%;
- d) gabapentin in an amount of about 6%;
- e) lidocaine hydrochloride monohydrate in an amount of about 3.7%;
- f) prilocaine hydrochloride in an amount of about 3.5%;
- g) vitamin E acetate in an amount of about 1%;
- h) sodium metabisulfite in an amount of about 0.5%;
- i) butylated hydroxytoluene in an amount of about 0.05%;
- and
- j) a pharmaceutically acceptable carrier in an amount of about 60.7%.
Dependencies are inferred from the claim text.